Boron neutron capture therapy (BNCT) for glioblastoma multiforme: A phase II study evaluating a prolonged high-dose of boronophenylalanine (BPA)☆
To access this article, please choose from the options below
☆ The study was conducted as a project within the Swedish Brain Tumour Study Group.
PII: S0167-8140(08)00114-X
doi:10.1016/j.radonc.2006.04.015
© 2008 Elsevier Ireland Ltd. All rights reserved.
